The main targets identified for the treatment of glioma are transferrin (Tf), folate, EGFR, vascular endothelial growth factor (VEGF), αvβ3 integrins, matrix metalloproteinases (MMP), and vascular cell adhesion molecule 1 (VCAM-1) [73]. This evidence concerns the gene VEGFA and central nervous system cancer.